Filing Details
- Accession Number:
- 0001209191-18-014228
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-27 18:56:07
- Reporting Period:
- 2018-02-26
- Accepted Time:
- 2018-02-27 18:56:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1435049 | Aduro Biotech Inc. | ADRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1714425 | Andrea Elsas Van | Kloosterstraat 9 Oss P7 5349 AB | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-26 | 6,874 | $6.48 | 216,669 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold to cover the tax obligation that occurred upon the vesting of the Restricted Stock Units granted to Reporting Person on February 23, 2017 for 51,700 shares.
Billionaire Hedge Funds
